# GDMC Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gdmc-pte

- Industry: Biotechnology
- Headquarters: Singapore, Singapore
- Total disclosed funding: $21M
- Latest round: Series A (Jan 24, 2024)
- Investors on record: 4

## About

Based in Singapore and founded in 2021 by CEO Michael S. Koeris, GDMC Pte. Ltd. designs and manufactures a diverse range of genetic medicine products, including both cataloged and customized mRNA and plasmid DNA. In January 2024, GMDC Pte. Ltd. raised USD 21 million in Series A funding led by investor Celadon Partners, with participation from other investors WI Harper Group, SEEDS Capital, and NSG Ventures.


GDMC provides a diverse range of products, including both cataloged and customized mRNA and plasmid DNA. The products are manufactured using advanced technology, ensuring unparalleled quality, purity, and consistency for reliable results in research and development endeavors. The company's Plasmid DNA (pDNA) offerings, specifically the GMP-Ready Grade, serve as critical starting materials for cell, gene, and nucleic acid therapeutics. GDMC's pDNA is characterized by its exceptional quality, facilitating a swift and dependable path to clinical applications. The mRNA products, available in Research Grade, encompass a carefully curated catalog of genes for use in proof-of-concept experiments or as positive controls. The company's core technologies emphasize early conceptualization, ensuring right-first-time (RFT) manufacturing with scalability and efficiency in mind. Through machine learning, GDMC's operations enable data-driven decisions and the incorporation of automation and digital systems into their processes.


The company plans to use the January 2024 funding to speed up the development of cutting-edge technology and enhance the efficiency of processes to reduce manufacturing costs for partners who want to move medications from clinical trials to commercialization.

## Funding rounds

- Series A, Jan 24, 2024, $21M — WI Harper Group, SEEDS Capital, Celadon Partners, NSG Ventures

## Investors

- WI Harper Group (https://capitalatlas.ai/funds/wi-harper-group) — Series A
- SEEDS Capital (https://capitalatlas.ai/funds/seeds-capital) — Series A
- Celadon Partners (https://capitalatlas.ai/funds/celadon-partners) — Series A
- NSG Ventures (https://capitalatlas.ai/funds/nsg-ventures) — Series A